Akero Therapeutics, Inc. (DELISTED) (AKRO:DL)
54.65
0.00 (0.00%)
USD |
NASDAQ |
Dec 18, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 4.499B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 90.35% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | -- |
| Price to Book Value | 4.698 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.0012 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 79.99% |
Profile
| N/A |
| URL | http://akerotx.com/ |
| Investor Relations URL | https://ir.akerotx.com/ |
| HQ State/Province | N/A |
| Sector | |
| Industry | |
| Next Earnings Release | Feb. 27, 2026 (est.) |
| Last Earnings Release | Nov. 10, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| N/A |
| URL | http://akerotx.com/ |
| Investor Relations URL | https://ir.akerotx.com/ |
| HQ State/Province | N/A |
| Sector | |
| Industry | |
| Next Earnings Release | Feb. 27, 2026 (est.) |
| Last Earnings Release | Nov. 10, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |